conray 325
sanofi-aventis new zealand limited - sodium iotalamate 54% - solution for injection - 54 % - active: sodium iotalamate 54%
conray 420
sanofi-aventis new zealand limited - sodium iotalamate 70% - solution for injection - 70 % - active: sodium iotalamate 70%
phenol in sodium iothalamate
biomed limited - phenol 120 mg/ml; sodium iotalamate 700 mg/ml - solution for injection - 12%/70% - active: phenol 120 mg/ml sodium iotalamate 700 mg/ml
cardio-conray
sanofi-aventis new zealand limited - meglumine iotalamate 52%; sodium iotalamate 26% - solution for injection - 52%/26% - active: meglumine iotalamate 52% sodium iotalamate 26%
meglumine iotalamate 600mg/ml (iodine 280mg/ml) / phenol 60mg/ml solution for injection 5ml ampoules
iodine 280mg/ml) / phenol 60mg/ml solution for injection 5ml ampoules (special order - phenol; meglumine iotalamate - solution for injection - 60mg/1ml ; 600mg/1ml
conray 280 14/50 micromol solution for injection
mallinckrodt uk commercial ltd - iotalamate meglumine - solution for injection - 14/50 micromol
conray 325
may & baker limited - iotalamate sodium - solution for injection - 325 mg/ml
conray 325
may & baker limited - iotalamate sodium - solution for injection - 325 mg/ml
conray 325
mallinckrodt uk limited - iotalamate sodium - solution for injection - 325 mg/ml
conray 325
mallinckrodt uk limited - iotalamate sodium - solution for injection - 50 millilitre